RFG
RIGL icon

Range Financial Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Range Financial Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-39,501
Closed -$1.07M – 214
2026
Q1 		$1.07M Sell
39,501
-6,437
-14% -$216K 0.36% 90
2025
Q4 		$1.97M Buy
45,938
+561
+1% +$21.1K 0.68% 47
2025
Q3 		$1.29M Buy
+45,377
New +$1.36M 0.46% 73

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Range Financial Group's RIGL Position: Q2 2026 in Review

Range Financial Group sold out of Rigel Pharmaceuticals (RIGL) in Q2 2026, closing a stake of 39,501 shares — an estimated $1.07M sold.

Range Financial Group first reported a position in RIGL in Q3 2025 and held it in 3 quarters. The position peaked at $1.97M in Q4 2025. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Range Financial Group reported no remaining Rigel Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Range Financial Group sold 39,501 Rigel Pharmaceuticals shares in Q2 2026, an estimated $1.07M.
  • Range Financial Group first reported a position in Rigel Pharmaceuticals in Q3 2025 and held it in 3 quarters.
  • Range Financial Group's Rigel Pharmaceuticals position peaked at $1.97M in Q4 2025.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Range Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.